
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles
Ji Liu, Jin Chang, Ying Jiang, et al.
Advanced Materials (2019) Vol. 31, Iss. 33
Open Access | Times Cited: 305
Ji Liu, Jin Chang, Ying Jiang, et al.
Advanced Materials (2019) Vol. 31, Iss. 33
Open Access | Times Cited: 305
Showing 1-25 of 305 citing articles:
Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2249
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2249
RNA delivery by extracellular vesicles in mammalian cells and its applications
Killian P. O’Brien, Koen Breyne, Stefano Ughetto, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 10, pp. 585-606
Open Access | Times Cited: 1424
Killian P. O’Brien, Koen Breyne, Stefano Ughetto, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 10, pp. 585-606
Open Access | Times Cited: 1424
Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing
Shuai Liu, Qiang Cheng, Tuo Wei, et al.
Nature Materials (2021) Vol. 20, Iss. 5, pp. 701-710
Open Access | Times Cited: 449
Shuai Liu, Qiang Cheng, Tuo Wei, et al.
Nature Materials (2021) Vol. 20, Iss. 5, pp. 701-710
Open Access | Times Cited: 449
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 426
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 426
Lipids and Lipid Derivatives for RNA Delivery
Yuebao Zhang, Changzhen Sun, Chang Wang, et al.
Chemical Reviews (2021) Vol. 121, Iss. 20, pp. 12181-12277
Open Access | Times Cited: 403
Yuebao Zhang, Changzhen Sun, Chang Wang, et al.
Chemical Reviews (2021) Vol. 121, Iss. 20, pp. 12181-12277
Open Access | Times Cited: 403
Self-assembled mRNA vaccines
Jeonghwan Kim, Yulia Eygeris, Mohit Gupta, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 83-112
Open Access | Times Cited: 383
Jeonghwan Kim, Yulia Eygeris, Mohit Gupta, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 83-112
Open Access | Times Cited: 383
An ionizable lipid toolbox for RNA delivery
Xuexiang Han, Hanwen Zhang, Kamila Butowska, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 369
Xuexiang Han, Hanwen Zhang, Kamila Butowska, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 369
CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 321
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 321
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
Min Qiu, Yan Tang, Jinjin Chen, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 8
Open Access | Times Cited: 320
Min Qiu, Yan Tang, Jinjin Chen, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 8
Open Access | Times Cited: 320
mRNA vaccine: a potential therapeutic strategy
Yang Wang, Ziqi Zhang, Jingwen Luo, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 313
Yang Wang, Ziqi Zhang, Jingwen Luo, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 313
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs
Sean A. Dilliard, Daniel J. Siegwart
Nature Reviews Materials (2023) Vol. 8, Iss. 4, pp. 282-300
Open Access | Times Cited: 311
Sean A. Dilliard, Daniel J. Siegwart
Nature Reviews Materials (2023) Vol. 8, Iss. 4, pp. 282-300
Open Access | Times Cited: 311
Therapeutic in vivo delivery of gene editing agents
Aditya Raguram, Samagya Banskota, David R. Liu
Cell (2022) Vol. 185, Iss. 15, pp. 2806-2827
Open Access | Times Cited: 297
Aditya Raguram, Samagya Banskota, David R. Liu
Cell (2022) Vol. 185, Iss. 15, pp. 2806-2827
Open Access | Times Cited: 297
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Dominik Witzigmann, Jayesh A. Kulkarni, Jerry Leung, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 344-363
Open Access | Times Cited: 284
Dominik Witzigmann, Jayesh A. Kulkarni, Jerry Leung, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 344-363
Open Access | Times Cited: 284
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing ofAngptl3
Min Qiu, Zachary Glass, Jinjin Chen, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 10
Open Access | Times Cited: 278
Min Qiu, Zachary Glass, Jinjin Chen, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 10
Open Access | Times Cited: 278
A Highly Sensitive CRISPR‐Empowered Surface Plasmon Resonance Sensor for Diagnosis of Inherited Diseases with Femtomolar‐Level Real‐Time Quantification
Fei Zheng, Zhi Chen, Jingfeng Li, et al.
Advanced Science (2022) Vol. 9, Iss. 14
Open Access | Times Cited: 234
Fei Zheng, Zhi Chen, Jingfeng Li, et al.
Advanced Science (2022) Vol. 9, Iss. 14
Open Access | Times Cited: 234
How can nanotechnology help to combat COVID-19? Opportunities and urgent need
Estefânia Vangelie Ramos Campos, Anderson do Espírito Santo Pereira, Jhones Luiz de Oliveira, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 210
Estefânia Vangelie Ramos Campos, Anderson do Espírito Santo Pereira, Jhones Luiz de Oliveira, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 210
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, et al.
Nanomaterials (2020) Vol. 10, Iss. 2, pp. 364-364
Open Access | Times Cited: 188
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, et al.
Nanomaterials (2020) Vol. 10, Iss. 2, pp. 364-364
Open Access | Times Cited: 188
In Situ Hypoxia-Induced Supramolecular Perylene Diimide Radical Anions in Tumors for Photothermal Therapy with Improved Specificity
Hua Wang, Ke-Fei Xue, Yuchong Yang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 5, pp. 2360-2367
Closed Access | Times Cited: 185
Hua Wang, Ke-Fei Xue, Yuchong Yang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 5, pp. 2360-2367
Closed Access | Times Cited: 185
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xiaoyu Xu, Chang Liu, Yonghui Wang, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113891-113891
Open Access | Times Cited: 183
Xiaoyu Xu, Chang Liu, Yonghui Wang, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113891-113891
Open Access | Times Cited: 183
Rational designs of in vivo CRISPR-Cas delivery systems
Cong‐Fei Xu, Guojun Chen, Ying‐Li Luo, et al.
Advanced Drug Delivery Reviews (2019) Vol. 168, pp. 3-29
Closed Access | Times Cited: 160
Cong‐Fei Xu, Guojun Chen, Ying‐Li Luo, et al.
Advanced Drug Delivery Reviews (2019) Vol. 168, pp. 3-29
Closed Access | Times Cited: 160
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Matthew Behr, Jing Zhou, Bing Xu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2150-2171
Open Access | Times Cited: 155
Matthew Behr, Jing Zhou, Bing Xu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 8, pp. 2150-2171
Open Access | Times Cited: 155
Lipid Nanoparticle–mRNA Formulations for Therapeutic Applications
Chang Wang, Yuebao Zhang, Yizhou Dong
Accounts of Chemical Research (2021) Vol. 54, Iss. 23, pp. 4283-4293
Open Access | Times Cited: 153
Chang Wang, Yuebao Zhang, Yizhou Dong
Accounts of Chemical Research (2021) Vol. 54, Iss. 23, pp. 4283-4293
Open Access | Times Cited: 153
A Coordinative Dendrimer Achieves Excellent Efficiency in Cytosolic Protein and Peptide Delivery
Lanfang Ren, Jia Lv, Hui Wang, et al.
Angewandte Chemie International Edition (2019) Vol. 59, Iss. 12, pp. 4711-4719
Closed Access | Times Cited: 151
Lanfang Ren, Jia Lv, Hui Wang, et al.
Angewandte Chemie International Edition (2019) Vol. 59, Iss. 12, pp. 4711-4719
Closed Access | Times Cited: 151
Emerging mRNA technologies: delivery strategies and biomedical applications
Yufen Xiao, Zhongmin Tang, Xiangang Huang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 10, pp. 3828-3845
Closed Access | Times Cited: 150
Yufen Xiao, Zhongmin Tang, Xiangang Huang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 10, pp. 3828-3845
Closed Access | Times Cited: 150
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
Pardis Kazemian, Si-Yue Yu, Sarah B. Thomson, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 6, pp. 1669-1686
Open Access | Times Cited: 150
Pardis Kazemian, Si-Yue Yu, Sarah B. Thomson, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 6, pp. 1669-1686
Open Access | Times Cited: 150